Safety of Janus kinase inhibitors compared to biologic therapy in patients with inflammatory bowel disease
{{output}}
Background/aims: There is a paucity of data regarding the comparative safety of Janus kinase inhibitors (JAKi) compared to biologic therapy in inflammatory bowel disease (IBD). ... ...
